This HTML5 document contains 118 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n8https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33500187
rdf:type
wikibase:Item
schema:description
scientific article published in April 2010 article científic vědecký článek наукова стаття, опублікована у квітні 2010 scienca artikolo 2010年論文 บทความทางวิทยาศาสตร์ tudományos cikk 2010年论文 научная статья 2010年の論文 artikulong pang-agham articol științific 2010年论文 научни чланак 2010年论文 2010年論文 artigo científico mokslinis straipsnis επιστημονικό άρθρο мақолаи илмӣ 2010年论文 vedecký článok artículu científicu espublizáu en 2010 научна статия 2010 nî lūn-bûn artikull shkencor 2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած 2010年论文 wetenschappelijk artikel artigo científico мақолаи илмӣ naučni članak scientific article published in April 2010 article scientifique 2010年论文 artykuł naukowy vetenskaplig artikel bài báo khoa học artigo científico artikel ilmiah videnskabelig artikel vitskapeleg artikkel 2010年論文 scientific article published in April 2010 2010 թվականի ապրիլին հրատարակված գիտական հոդված articolo scientifico სამეცნიერო სტატია מאמר מדעי ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículo científico publicado en 2010 مقالة علمية نشرت في أبريل 2010 2010년 논문 tieteellinen artikkeli teaduslik artikkel 2010年論文 article scientific bilimsel makale научни чланак wissenschaftlicher Artikel vitenskapelig artikkel 2010年論文
p:P577
wds:Q33500187-56FEFEC3-C57C-4913-8891-358BCBC4BBB5
wdt:P577
2010-04-01T00:00:00Z
p:P2888
wds:Q33500187-B5863DA8-2C22-410A-B041-9981BCE585CF
wdt:P2888
n8:s00280-009-1106-6
p:P2860
wds:Q33500187-92304F74-F53F-43D0-B0A3-DD157CBE82F8 wds:Q33500187-3BDA1DB2-B4A6-42CA-827F-986A0897AFBD
wdt:P2860
wd:Q37486791 wd:Q28344185
p:P2093
wds:Q33500187-71B8E276-8E4D-4691-9C4A-3D3D6B287272 wds:Q33500187-7C06F04E-ECE9-4F24-95A1-3F3CC05C4D31 wds:Q33500187-10358BC8-81C3-424D-B195-29E3293E1B1A wds:Q33500187-B623A76E-301E-4552-8AED-09704558E78A
wdt:P2093
Rhys D Clyburn Catherine A Evans Penny Reid Diane V Lefley
rdfs:label
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy
skos:prefLabel
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy
schema:name
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy
p:P50
wds:Q33500187-838166A7-D753-44B7-9585-4706265CFCB8
wdt:P50
wd:Q58218901
p:P1476
wds:Q33500187-ADD44E3A-D9C2-4330-BD2D-0539D883C308
wdt:P1476
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy
p:P304
wds:Q33500187-0D86934C-FD79-4F32-ABA1-FDBA7AFF9DFF
wdt:P304
969-978
p:P31
wds:Q33500187-71B72D62-CD0D-4288-8DC3-FA49F024D8A5
wdt:P31
wd:Q13442814
p:P921
wds:Q33500187-828EF5DD-991D-4C62-A9F4-422B542A1304 wds:Q33500187-C6AF8DCC-7196-4354-AEE9-7EA32EF53A9A wds:Q33500187-C7EBF688-AD18-42CF-A40E-4DAB67BBB3E7
wdt:P921
wd:Q181257 wd:Q218507 wd:Q18936
p:P698
wds:Q33500187-FE9D28DA-D498-4783-B552-612AB4C7EA50
wdtn:P698
n12:19730863
wdt:P698
19730863
p:P1433
wds:Q33500187-D7451450-497F-4071-94D3-D9AD7C1A954D
wdt:P1433
wd:Q326137
p:P433
wds:Q33500187-FEB17101-63B2-4139-9783-8A0E3541389B
p:P478
wds:Q33500187-810AEF17-2957-4A76-B4A6-88D033CDFD4B
wdt:P433
5
wdt:P478
65
p:P356
wds:Q33500187-F1BE7BB9-D674-48B0-A29C-0432F83D5288
wdtn:P356
n11:S00280-009-1106-6
wdt:P356
10.1007/S00280-009-1106-6
p:P5875
wds:Q33500187-C5140230-3548-498A-9509-3DA7388BD397
wdt:P5875
26790000
p:P6179
wds:Q33500187-03D70CC6-C841-48AD-8816-18F06952E088
wdt:P6179
1000742094